Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Feasibility Study of the Placement, Use, and Safety of the Nucleus 24 Auditory Brainstem Implant in Non-Neurofibromatosis Type 2 (NF2) Pediatric Patients

NCT01850225 is registered in ClinicalTrials.gov with House Research Institute as lead sponsor.

NCT NCT01850225
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01850225 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Feasibility Study of the Placement, Use, and Safety of the Nucleus 24 Auditory Brainstem Implant in Non-Neurofibromatosis Type 2 (NF2) Pediatric Patients
Lead sponsor
House Research Institute
Phase
Phase 1
Overall status
Withdrawn
Start date
October 31, 2013
Completion date
September 30, 2017
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bilateral cochlear aplasia, bilateral cochlear nerve deficiency, bilateral cochlear ossification secondary to meningitis